ArticleNucleic acids research2026
DNA-damage dependent interaction of Orc6 to SMARCA1 in S-phase modulates chromatin remodeling.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The human Origin Recognition Complex subunit 6 has recently garnered significant attention. The loss of human Orc6 doesn't impact MCM loading in vivo, while in vitro reconstitution experiments have demonstrated that MCM loading can occur without Orc6, though could be stimulated upon the addition of Orc6. We recently reported an unexpected role for hOrc6, in promoting S-phase progression post pre-RC assembly and DNA damage response (DDR). Using CUT&RUN to map the binding of Orc6 genome-wide, we find that Orc6 is present at replication origins and at sites of DNA damage during S-phase. Upon encountering oxidative damage in S-phase, Orc6 interacts with the chromatin remodelers, SMARCA1/SNF2L, also a component of the replication fork. Loss of Orc6 shows enhanced genome-wide association of SMARCA1 to Orc6-bound sites, concomitant with chromatin remodeling at these sites supporting the model that Orc6 is a negative regulator of SMARCA1 and constrains its localization. Upon DNA damage, enhanced association of Orc6 to SMARCA1 prevents chromatin remodeling activity to halt replication progression. We propose that during S-phase, Orc6 is a barrier factor, which limits the activity of chromatin remodelers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.